tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide

C92H99Cl4N17O19S — CID 157069296

IUPACtert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide
SMILESCC1(O)CNC1.CNc1ccc2cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n(CC(=O)N3CC(C)(O)C3)c2n1.CNc1ccc2cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n(CC(=O)O)c2n1.CNc1ccc2cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n(CC(=O)OC(C)(C)C)c2n1.Cc1ccc2cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n(CC(=O)OC(C)(C)C)c2n1.O=S=O
InChIInChI=1S/C23H24ClN5O4.C23H25ClN4O4.C23H24ClN3O4.C19H17ClN4O4.C4H9NO.O2S/c1-23(33)12-28(13-23)19(30)11-29-20-15(5-8-18(25-2)27-20)9-17(22(29)32)21(31)26-10-14-3-6-16(24)7-4-14;1-23(2,3)32-19(29)13-28-20-15(7-10-18(25-4)27-20)11-17(22(28)31)21(30)26-12-14-5-8-16(24)9-6-14;1-14-5-8-16-11-18(21(29)25-12-15-6-9-17(24)10-7-15)22(30)27(20(16)26-14)13-19(28)31-23(2,3)4;1-21-15-7-4-12-8-14(19(28)24(10-16(25)26)17(12)23-15)18(27)22-9-11-2-5-13(20)6-3-11;1-4(6)2-5-3-4;1-3-2/h3-9,33H,10-13H2,1-2H3,(H,25,27)(H,26,31);5-11H,12-13H2,1-4H3,(H,25,27)(H,26,30);5-11H,12-13H2,1-4H3,(H,25,29);2-8H,9-10H2,1H3,(H,21,23)(H,22,27)(H,25,26);5-6H,2-3H2,1H3;
InChIKeyACFWAAJFXPXTFC-UHFFFAOYSA-N
MW1920.78 g/mol
LogP9.38
Rot. Bonds23

About tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide

tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide (PubChem CID 157069296) has the molecular formula C92H99Cl4N17O19S and a molecular weight of 1920.78 g/mol. Its IUPAC name is tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide.

Molecular Properties

Compound Nametert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide
PubChem CID157069296
Molecular FormulaC92H99Cl4N17O19S
Molecular Weight1920.78 g/mol
Exact Mass1917.58
IUPAC Nametert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide
SMILESCC1(O)CNC1.CNc1ccc2cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n(CC(=O)N3CC(C)(O)C3)c2n1.CNc1ccc2cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n(CC(=O)O)c2n1.CNc1ccc2cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n(CC(=O)OC(C)(C)C)c2n1.Cc1ccc2cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n(CC(=O)OC(C)(C)C)c2n1.O=S=O
InChIInChI=1S/C23H24ClN5O4.C23H25ClN4O4.C23H24ClN3O4.C19H17ClN4O4.C4H9NO.O2S/c1-23(33)12-28(13-23)19(30)11-29-20-15(5-8-18(25-2)27-20)9-17(22(29)32)21(31)26-10-14-3-6-16(24)7-4-14;1-23(2,3)32-19(29)13-28-20-15(7-10-18(25-4)27-20)11-17(22(28)31)21(30)26-12-14-5-8-16(24)9-6-14;1-14-5-8-16-11-18(21(29)25-12-15-6-9-17(24)10-7-15)22(30)27(20(16)26-14)13-19(28)31-23(2,3)4;1-21-15-7-4-12-8-14(19(28)24(10-16(25)26)17(12)23-15)18(27)22-9-11-2-5-13(20)6-3-11;1-4(6)2-5-3-4;1-3-2/h3-9,33H,10-13H2,1-2H3,(H,25,27)(H,26,31);5-11H,12-13H2,1-4H3,(H,25,27)(H,26,30);5-11H,12-13H2,1-4H3,(H,25,29);2-8H,9-10H2,1H3,(H,21,23)(H,22,27)(H,25,26);5-6H,2-3H2,1H3;
InChIKeyACFWAAJFXPXTFC-UHFFFAOYSA-N
XLogP9.38
TPSA488.89 Ų
H-Bond Donors11
H-Bond Acceptors30
Rotatable Bonds23
Heavy Atoms133
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001920.78
LogP ≤ 59.38
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1030

Analyze tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide?
The IUPAC name of tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide (CID 157069296) is tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide.
What is the SMILES notation for tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide?
The canonical SMILES for tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide is CC1(O)CNC1.CNc1ccc2cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n(CC(=O)N3CC(C)(O)C3)c2n1.CNc1ccc2cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n(CC(=O)O)c2n1.CNc1ccc2cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n(CC(=O)OC(C)(C)C)c2n1.Cc1ccc2cc(C(=O)NCc3ccc(Cl)cc3)c(=O)n(CC(=O)OC(C)(C)C)c2n1.O=S=O.
What is the InChIKey of tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide?
The InChIKey is ACFWAAJFXPXTFC-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H24ClN5O4.C23H25ClN4O4.C23H24ClN3O4.C19H17ClN4O4.C4H9NO.O2S/c1-23(33)12-28(13-23)19(30)11-29-20-15(5-8-18(25-2)27-20)9-17(22(29)32)21(31)26-10-14-3-6-16(24)7-4-14;1-23(2,3)32-19(29)13-28-20-15(7-10-18(25-4)27-20)11-17(22(28)31)21(30)26-12-14-5-8-16(24)9-6-14;1-14-5-8-16-11-18(21(29)25-12-15-6-9-17(24)10-7-15)22(30)27(20(16)26-14)13-19(28)31-23(2,3)4;1-21-15-7-4-12-8-14(19(28)24(10-16(25)26)17(12)23-15)18(27)22-9-11-2-5-13(20)6-3-11;1-4(6)2-5-3-4;1-3-2/h3-9,33H,10-13H2,1-2H3,(H,25,27)(H,26,31);5-11H,12-13H2,1-4H3,(H,25,27)(H,26,30);5-11H,12-13H2,1-4H3,(H,25,29);2-8H,9-10H2,1H3,(H,21,23)(H,22,27)(H,25,26);5-6H,2-3H2,1H3;.
What are the key properties of tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide?
tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide has a molecular weight of 1920.78 g/mol, XLogP of 9.38, 23 rotatable bonds, 11 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetate;tert-butyl 2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-methyl-2-oxo-1,8-naphthyridin-1-yl]acetate;2-[3-[(4-chlorophenyl)methylcarbamoyl]-7-(methylamino)-2-oxo-1,8-naphthyridin-1-yl]acetic acid;N-[(4-chlorophenyl)methyl]-1-[2-(3-hydroxy-3-methylazetidin-1-yl)-2-oxoethyl]-7-(methylamino)-2-oxo-1,8-naphthyridine-3-carboxamide;3-methylazetidin-3-ol;sulfur dioxide is sourced from PubChem (CID 157069296), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).